LCFA/IASLC Translational Thoracic Oncology Research Grants
The LCFA/IASLC Translational Thoracic Oncology Research Grants fund early-career scientists advancing translational research to improve lung cancer detection, diagnosis, and patient care.
Funder: International Association for the Study of Lung Cancer
Due Dates: January 14, 2027: Full application deadline
Funding Amounts: $100,000 per year, up to 2 years ($200,000 total per award)
Summary: Supports early-career investigators conducting translational research to improve detection, diagnosis, and care for lung cancer patients.
Key Information: No indirect costs allowed; up to 50% of budget may be used for salary/fringe.
Description
The LCFA/IASLC Translational Thoracic Oncology Research Grants are a collaborative initiative between the Lung Cancer Foundation of America (LCFA) and the International Association for the Study of Lung Cancer (IASLC). The program is designed to advance innovative translational research in lung cancer, with a focus on projects that have the potential for immediate or near-term impact on patient care. Emphasis is placed on supporting early-career investigators aiming to improve the detection, diagnosis, and treatment of thoracic malignancies, as well as reducing disparities and improving outcomes for underrepresented populations.
